NCT02474199: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02474199 |
|---|---|
| Title | Safety of Donor Alloantigen Reactive Tregs to Facilitate Minimization and/or Discontinuation of Immunosuppression in Adult Liver Transplant Recipients (CTOTC-12) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | June 6, 2016 |
| Completion date | Dec. 16, 2019 |
| Required reporting date | Dec. 15, 2020, midnight |
| Actual reporting date | Dec. 8, 2020 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |